BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35619256)

  • 1. Trabectedin in Cancers: Mechanisms and Clinical Applications.
    Wang J; Wang P; Zeng Z; Lin C; Lin Y; Cao D; Ma W; Xu W; Xiang Q; Luo L; Wang W; Shi Y; Gao Z; Zhao Y; Liu H; Liu SL
    Curr Pharm Des; 2022; 28(24):1949-1965. PubMed ID: 35619256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabectedin as a chemotherapy option for patients with BRCA deficiency.
    Monk BJ; Lorusso D; Italiano A; Kaye SB; Aracil M; Tanović A; D'Incalci M
    Cancer Treat Rev; 2016 Nov; 50():175-182. PubMed ID: 27710871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trabectedin : a review of its use in the management of soft tissue sarcoma and ovarian cancer.
    Carter NJ; Keam SJ
    Drugs; 2007; 67(15):2257-76. PubMed ID: 17927287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trabectedin for the treatment of soft tissue sarcomas.
    De Sanctis R; Marrari A; Santoro A
    Expert Opin Pharmacother; 2016 Aug; 17(11):1569-77. PubMed ID: 27328277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trabectedin: novel insights in the treatment of advanced sarcoma.
    Lopez JP; Gajdos C; Elias A
    Curr Oncol Rep; 2014 Jun; 16(6):387. PubMed ID: 24756367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trabectedin in soft tissue sarcomas.
    Petek BJ; Loggers ET; Pollack SM; Jones RL
    Mar Drugs; 2015 Feb; 13(2):974-83. PubMed ID: 25686274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trabectedin in soft tissue sarcomas.
    Brodowicz T
    Future Oncol; 2014 Jun; 10(8 Suppl):s1-5. PubMed ID: 25048043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives.
    Gordon EM; Sankhala KK; Chawla N; Chawla SP
    Adv Ther; 2016 Jul; 33(7):1055-71. PubMed ID: 27234989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trabectedin, a drug acting on both cancer cells and the tumour microenvironment.
    D'Incalci M; Badri N; Galmarini CM; Allavena P
    Br J Cancer; 2014 Aug; 111(4):646-50. PubMed ID: 24755886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trabectedin: a review of its use in soft tissue sarcoma and ovarian cancer.
    Carter NJ; Keam SJ
    Drugs; 2010 Feb; 70(3):355-76. PubMed ID: 20166769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabectedin's contribution to the treatment of sarcomas.
    Blay JY
    Expert Rev Anticancer Ther; 2013 Jun; 13(6 Suppl 1):3-9. PubMed ID: 23638729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trabectedin (ET-743/Yondelis) for treating soft tissue sarcomas and ovarian cancer].
    Gennigens C; Jerusalem G
    Rev Med Liege; 2011; 66(7-8):452-5. PubMed ID: 21942081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabectedin for the treatment of breast cancer.
    D'Incalci M; Zambelli A
    Expert Opin Investig Drugs; 2016; 25(1):105-15. PubMed ID: 26592307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13 years of trabectedin, 5 years of Yondelis®: what have we learnt?
    Le Cesne A
    Expert Rev Anticancer Ther; 2013 Jun; 13(6 Suppl 1):11-9. PubMed ID: 23638726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.
    Schmitt T; Keller E; Dietrich S; Wuchter P; Ho AD; Egerer G
    Mar Drugs; 2010 Oct; 8(10):2647-58. PubMed ID: 21116412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabectedin and radiotherapy in soft tissue sarcomas: friends or foes?
    Assi T; Cesne AL
    Future Oncol; 2023 Sep; 19(28):1893-1896. PubMed ID: 37781755
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience of the use of trabectedin (ET-743, Yondelis) in 21 patients with pre-treated advanced sarcoma from a single centre.
    Roylance R; Seddon B; McTiernan A; Sykes K; Daniels S; Whelan J
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):572-6. PubMed ID: 17624747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with trabectedin: should be indicated to all soft tissue sarcoma histotypes?
    Grivas A; Trafalis DT; Thanopoulou E; Ziras NG; Athanasiou AE
    J BUON; 2010; 15(4):791-3. PubMed ID: 21229647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation of trabectedin in treatment of soft-tissue sarcomas.
    Martin-Liberal J; Judson I
    Expert Opin Drug Saf; 2013 Nov; 12(6):905-11. PubMed ID: 23937190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.